• 1. Excimer and exciplex formation in a pair of bright phosphorescent isomers constructed from Cu3(pyrazolate)3 and Cu3I3 coordination luminophores?
  Shun-Ze Zhan,Mian Li,Xiao-Ping Zhou,Dan Li,Seik Weng Ng RSC Adv., 2011,1, 1457-1459
• 2. Exchanged ligands on the surface of a giant cluster: [(MoO3)176(H2O)63(CH3OH)17Hn](32 – n)–
  Chem. Commun., 1998, 1501-1502
• 3. Examination of the hydrogen-bonding networks in small water clusters (n = 2–5, 13, 17) using absolutely localized molecular orbital energy decomposition analysis?
  Erika A. Cobar,Paul R. Horn,Robert G. Bergman,Martin Head-Gordon Phys. Chem. Chem. Phys., 2012,14, 15328-15339
• 4. Emerging investigator series: bacteriophages as nano engineering tools for quality monitoring and pathogen detection in water and wastewater
  Fereshteh Bayat Environ. Sci.: Nano, 2021,8, 367-389
• 5. Essential effect of the electrolyte on the mechanical and chemical degradation of LiNi0.8Co0.15Al0.05O2 cathodes upon long-term cycling??
  Xiaoming Liu,Zachary D. Hood,Wangda Li,Donovan N. Leonard,Arumugam Manthiram,Miaofang Chi J. Mater. Chem. A, 2021,9, 2111-2119

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles 4,5-disubstituted oxazoles
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles Oxazoles 4,5-disubstituted oxazoles

Introduction to 5-ethyl-1,3-oxazole-4-carboxylic acid (CAS No. 898227-93-5)

5-ethyl-1,3-oxazole-4-carboxylic acid, identified by the Chemical Abstracts Service registry number 898227-93-5, is a heterocyclic compound that has garnered significant attention in the field of pharmaceutical chemistry and medicinal research. This compound belongs to the oxazole family, a class of molecules characterized by a five-membered ring containing one oxygen atom and two carbon atoms, which often exhibits remarkable biological activity. The presence of an ethyl group at the 5-position and a carboxylic acid moiety at the 4-position introduces unique functional properties that make this compound a valuable scaffold for drug discovery and development.

The structure of 5-ethyl-1,3-oxazole-4-carboxylic acid imparts distinct chemical and pharmacological characteristics. The oxazole ring itself is known for its stability and ability to engage in hydrogen bonding, making it a common motif in biologically active molecules. The carboxylic acid group not only serves as a site for further functionalization but also contributes to the compound's solubility and reactivity. The ethyl substituent at the 5-position modulates the electronic properties of the ring, influencing its interactions with biological targets.

In recent years, there has been growing interest in oxazole derivatives due to their diverse pharmacological profiles. Studies have demonstrated that oxazole-based compounds exhibit activities ranging from antimicrobial to anti-inflammatory effects. Specifically, 5-ethyl-1,3-oxazole-4-carboxylic acid has been investigated for its potential in modulating enzyme activity and receptor binding. Its unique structural features make it an attractive candidate for further exploration in medicinal chemistry.

One of the most compelling aspects of 5-ethyl-1,3-oxazole-4-carboxylic acid is its versatility as a building block in drug design. The carboxylic acid functionality can be readily converted into other pharmacophores such as esters, amides, or acyl chlorides, enabling the synthesis of a wide array of derivatives with tailored biological activities. This flexibility has made it a focal point in efforts to develop novel therapeutic agents.

Recent research has highlighted the potential of 5-ethyl-1,3-oxazole-4-carboxylic acid in addressing specific therapeutic challenges. For instance, studies have explored its interaction with enzymes involved in metabolic pathways relevant to diseases such as diabetes and cancer. The compound's ability to modulate these enzymes suggests its utility in developing treatments targeting these conditions. Additionally, its oxazole core has been shown to exhibit inhibitory effects on certain kinases, which are key targets in oncology research.

The synthesis of 5-ethyl-1,3-oxazole-4-carboxylic acid (CAS No. 898227-93-5) involves multi-step organic reactions that highlight the ingenuity of synthetic chemists. Traditional methods often employ cyclization reactions to construct the oxazole ring, followed by functional group transformations to introduce the ethyl and carboxylic acid moieties. Advances in synthetic methodologies have enabled more efficient and scalable production processes, making this compound more accessible for research purposes.

In terms of pharmacokinetic properties, 5-ethyl-1,3-oxazole-4-carboxylic acid demonstrates promising characteristics that are essential for drug development. Preliminary studies indicate good oral bioavailability and moderate metabolic stability, suggesting its potential for clinical translation. Furthermore, its solubility profile allows for formulation into various dosage forms, enhancing its therapeutic applicability.

The role of computational chemistry in understanding the behavior of 5-ethyl-1,3-oxazole-4-carboxylic acid cannot be overstated. Molecular modeling techniques have been employed to predict its binding affinity to biological targets and to rationalize its pharmacological effects. These computational approaches complement experimental studies by providing insights into the molecular interactions that underpin its biological activity.

Future directions in research on 5-ethyl-1,3-oxtaole - 4 - carboxylic acid (CAS No. 898227 - 93 - 5) include exploring its potential as an intermediate in the synthesis of more complex drug candidates. By leveraging its structural features and reactivity patterns, researchers aim to develop novel therapeutics with enhanced efficacy and reduced side effects. Collaborative efforts between academic institutions and pharmaceutical companies are likely to accelerate these endeavors.

The growing body of evidence supporting the utility of 5 - ethyl - 1 , 3 - oxazole - 4 - carboxylic acid underscores its significance in modern medicinal chemistry. As our understanding of biological pathways continues to expand, compounds like this one will play an increasingly important role in addressing unmet medical needs. Their unique structural features and versatile chemical properties make them indispensable tools for drug discovery and development.

• 103879-58-9(5-Methyl-1,3-oxazole-4-carboxylic acid)
• 89007-02-3(4-Oxazolecarboxylic acid, 5-pentyl-, methyl ester)
• 166950-00-1(Methyl 5-(2-aminoethyl)oxazole-4-carboxylate)
• 23000-14-8(dimethyl-1,3-oxazole-4-carboxylic acid)
• 89007-03-4(4-Oxazolecarboxylic acid, 5-pentyl-)
• 917828-31-0(5-cyclopropyl-1,3-oxazole-4-carboxylic acid)
• 89006-96-2(5-(propan-2-yl)-1,3-oxazole-4-carboxylic acid)
• 113366-75-9(4-Oxazolecarboxylicacid, 5-ethyl-2-methyl-)
• 113366-77-1(2-Ethyl-5-methyl-1,3-oxazole-4-carboxylic Acid)
• 72030-85-4(methyl 5-(propan-2-yl)-1,3-oxazole-4-carboxylate)